GALT insider transaction filings
GALECTIN THERAPEUTICS INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen GALT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Uihlein Richard E — Director, 10% owner | Option exercise (M): 31,825,235 @ $3 · Option exercise (M): 2,550,932 @ $4.05 · Option exercise (M) @ $95,475,705 · Option exercise (M) @ $10,331,275 | EDGAR |
| 2026-07-16 | 4 | Jamil Khurram — Chief Medical Officer | Option exercise (M): 16,250 @ $3.04 · Sale (S): 16,250 @ $5.13 · Option exercise (M): 16,250 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Shlevin Harold H. — Director | Option exercise (M): 7,732 @ $1.23 · Sale (S): 7,732 @ $5 · Option exercise (M): 22,268 @ $1.23 · Sale (S): 22,268 @ $5.04 · Option exercise (M): 7,732 (derivative) @ $0 · Option exercise (M): 22,268 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Jamil Khurram — Chief Medical Officer | Option exercise (M): 2,037 @ $2.20 · Sale (S): 2,037 @ $5 · Option exercise (M): 2,533 @ $2.50 · Sale (S): 2,533 @ $5 · Option exercise (M): 47,467 @ $2.50 · Sale (S): 47,467 @ $5.04 · +3 more | EDGAR |
| 2026-06-25 | 4 | Jamil Khurram — Chief Medical Officer | Option exercise (M): 7,557 @ $1.23 · Sale (S): 7,557 @ $3.14 · Option exercise (M): 7,557 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Jamil Khurram — Chief Medical Officer | Option exercise (M): 568 @ $1.23 · Sale (S): 568 @ $3.10 · Option exercise (M): 568 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Brem Henry — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | ELDRED KARY — Director | Purchase (P): 300 @ $2.70 | EDGAR |
| 2026-01-22 | 4/A | LEWIS JOEL — President and CEO, Director | Grant/award (A): 91,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | CARSON BENJAMIN SR — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Zordani Richard A. Jr. — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Jamil Khurram — Chief Medical Officer | Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | FREEMAN KEVIN D — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | ELDRED KARY — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | LEWIS JOEL — President and CEO, Director | Grant/award (A): 84,000 (derivative) @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | CALLICUTT JACK W — Chief Financial Officer | Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Shlevin Harold H. — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | OMENN GILBERT S — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | AMELIO GILBERT F — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Schwartz Elissa J. — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Uihlein Richard E — Director, 10% owner | Grant/award (A): 13,158 @ $3.04 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | LEWIS JOEL — President and CEO, Director | Code (?): 56,332 @ $3.88 | EDGAR |
| 2026-01-06 | 4 | LEWIS JOEL — President and CEO, Director | Option exercise (M): 84,000 @ $0 · Sale (S): 18,571 @ $4.20 · Sale (S): 27,731 @ $3.91 · Sale (S): 37,698 @ $3.58 · Option exercise (M): 84,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | CALLICUTT JACK W — Chief Financial Officer | Option exercise (M): 60,000 @ $0 · Sale (S): 13,914 @ $4.20 · Sale (S): 25,732 @ $3.90 · Sale (S): 20,354 @ $3.67 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Jamil Khurram — Chief Medical Officer | Option exercise (M): 60,000 @ $0 · Sale (S): 13,055 @ $4.20 · Sale (S): 25,499 @ $3.90 · Sale (S): 21,446 @ $3.65 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Jamil Khurram — Chief Medical Officer | Option exercise (M): 8,125 @ $1.23 · Sale (S): 8,125 @ $4.07 · Option exercise (M): 8,125 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | ELDRED KARY — Director | Purchase (P): 700 @ $3.73 | EDGAR |
| 2025-12-23 | 4 | FREEMAN KEVIN D — Director | Purchase (P): 5,500 @ $3.55 | EDGAR |
| 2025-12-23 | 4 | ELDRED KARY — Director | Purchase (P): 700 @ $3.73 | EDGAR |
| 2025-12-23 | 4/A | FREEMAN KEVIN D — Director | Purchase (P): 5,500 @ $3.55 | EDGAR |
| 2025-12-23 | 4/A | FREEMAN KEVIN D — Director | Purchase (P): 5,500 @ $3.55 | EDGAR |
| 2025-12-19 | 4 | LEWIS JOEL — President and CEO, Director | Option exercise (M): 7,829 @ $2.86 · Sale (S): 7,829 @ $7.06 · Option exercise (M): 7,829 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Jamil Khurram — Chief Medical Officer | Sale (S): 4,479 @ $7.04 · Option exercise (M): 6,463 @ $2.20 · Sale (S): 6,463 @ $7.04 · Option exercise (M): 8,500 @ $2.50 · Sale (S): 8,500 @ $7.04 · Option exercise (M): 6,463 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-19 | 4 | Shlevin Harold H. — Director | Option exercise (M): 20,000 @ $1.98 · Sale (S): 19,793 @ $7.04 · Sale (S): 4,706 @ $7.04 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | 10X Fund, L.P. — 10% owner 10X Capital Management, LLC — 10% owner CZIRR JAMES C — 10% owner | Other (J): 24,000 · Sale (S): 30,681 @ $6.66 | EDGAR |
| 2025-12-16 | 4 | Shlevin Harold H. — Director | Option exercise (M): 19,793 @ $4.16 · Sale (S): 19,793 @ $6.27 · Option exercise (M): 8,417 @ $4.16 · Sale (S): 8,417 @ $6.30 · Option exercise (M): 19,793 (derivative) @ $0 · Option exercise (M): 8,417 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Shlevin Harold H. — Director | Sale (S): 4,000 @ $6.00 · Option exercise (M): 35,000 @ $2.86 · Sale (S): 35,000 @ $5.95 · Option exercise (M): 20,000 @ $2.11 · Sale (S): 20,000 @ $5.96 · Option exercise (M): 20,000 @ $1.98 · +16 more | EDGAR |
| 2025-12-08 | 4/A | 10X Fund, L.P. — 10% owner 10X Capital Management, LLC — 10% owner CZIRR JAMES C — 10% owner | Sale (S): 30,000 @ $5.47 · Sale (S): 132,069 @ $5.73 | EDGAR |
| 2025-12-04 | 4 | 10X Fund, L.P. — 10% owner 10X Capital Management, LLC — 10% owner CZIRR JAMES C — 10% owner | Sale (S): 30,000 @ $5.47 · Sale (S): 120,000 @ $5.73 | EDGAR |
| 2025-11-19 | 4 | LEWIS JOEL — President and CEO, Director | Option exercise (M): 15,680 @ $2.39 · Sale (S): 15,680 @ $6.04 · Option exercise (M): 6,783 @ $2.39 · Sale (S): 6,783 @ $6.15 · Option exercise (M): 15,680 (derivative) @ $0 · Option exercise (M): 6,783 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | CALLICUTT JACK W — Chief Financial Officer | Option exercise (M): 9,586 @ $1.98 · Sale (S): 9,586 @ $6.03 · Option exercise (M): 19,701 @ $1.11 · Sale (S): 19,701 @ $6.03 · Option exercise (M): 2,323 @ $1.23 · Sale (S): 2,323 @ $6.03 · +9 more | EDGAR |
| 2025-11-14 | 4 | Jamil Khurram — Chief Medical Officer | Sale (S): 21,867 @ $5.47 · Option exercise (M): 41,500 @ $2.20 · Sale (S): 41,500 @ $5.47 · Option exercise (M): 41,500 @ $2.50 · Sale (S): 41,500 @ $5.47 · Option exercise (M): 16,250 @ $1.23 · +4 more | EDGAR |
| 2025-11-12 | 4 | 10X Fund, L.P. — 10% owner 10X Capital Management, LLC — 10% owner CZIRR JAMES C — 10% owner | Sale (S): 40,000 @ $5.25 | EDGAR |
| 2025-11-12 | 4 | LEWIS JOEL — President and CEO, Director | Option exercise (M): 1,867 @ $2.39 · Sale (S): 1,867 @ $6.03 · Option exercise (M): 1,867 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | CALLICUTT JACK W — Chief Financial Officer | Option exercise (M): 1,880 @ $1.98 · Sale (S): 1,880 @ $6.02 · Option exercise (M): 1,675 @ $1.11 · Sale (S): 1,675 @ $6.03 · Option exercise (M): 1,736 @ $1.23 · Sale (S): 1,736 @ $6.03 · +3 more | EDGAR |
| 2025-11-07 | 4 | LEWIS JOEL — President and CEO, Director | Option exercise (M): 200 @ $2.39 · Sale (S): 200 @ $6 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | CALLICUTT JACK W — Chief Financial Officer | Option exercise (M): 200 @ $1.98 · Sale (S): 200 @ $6 · Option exercise (M): 200 @ $1.11 · Sale (S): 200 @ $6 · Option exercise (M): 200 @ $1.72 · Sale (S): 200 @ $6 · +3 more | EDGAR |
| 2025-11-05 | 4 | LEWIS JOEL — President and CEO, Director | Option exercise (M): 1,300 @ $2.39 · Sale (S): 1,300 @ $6.01 · Option exercise (M): 14,420 @ $2.39 · Sale (S): 14,420 @ $6.07 · Option exercise (M): 1,300 (derivative) @ $0 · Option exercise (M): 14,420 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | CALLICUTT JACK W — Chief Financial Officer | Option exercise (M): 1,300 @ $1.98 · Sale (S): 1,300 @ $6.01 · Option exercise (M): 1,260 @ $1.11 · Sale (S): 1,260 @ $6.01 · Option exercise (M): 1,250 @ $1.72 · Sale (S): 1,250 @ $6.01 · +12 more | EDGAR |
| 2025-10-24 | 4 | 10X Fund, L.P. — 10% owner 10X Capital Management, LLC — 10% owner CZIRR JAMES C — 10% owner | Sale (S): 20,000 @ $4.93 · Sale (S): 30,000 @ $4.94 | EDGAR |
Recent 8-K events — GALECTIN THERAPEUTICS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GALT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →